11 – 20 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Moharram, Sausan A. LU ; Shah, Kinjal LU ; Khanum, Fatima ; Rönnstrand, Lars LU
and Kazi, Julhash U.
LU
(2019)
In Blood Cancer Journal
9(2).
- Contribution to journal › Letter
-
Mark
The role of SRC family kinases in FLT3 signaling
Kazi, Julhash U. LU
and Rönnstrand, Lars
LU
(2019)
In International Journal of Biochemistry and Cell Biology
107.
p.32-37
- Contribution to journal › Scientific review
-
Mark
FMS-like Tyrosine Kinase 3/FLT3 : From Basic Science to Clinical Implications
- Contribution to journal › Article
-
Mark
Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer
Nordgaard, Cathrine ; Doll, Sophia ; Matos, Ana Laura de Souza Almeida ; Høeberg, Mikkel ; Kazi, Julhash Uddin LU
; Friis, Stine
; Stenvang, Jan
; Rönnstrand, Lars
LU
; Mann, Matthias
and Manuel Afonso Moreira, José
(2019)
In Molecular Oncology
13(12).
p.2646-2662
- Contribution to journal › Article
- 2018
-
Mark
SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
Rupar, Kaja ; Moharram, Sausan A. LU ; Kazi, Julhash U. LU
and Rönnstrand, Lars
LU
(2018)
In Scientific Reports
8(1).
- Contribution to journal › Article
-
Mark
XK-related protein 5 (XKR5) is a novel negative regulator of KIT/D816V-mediated transformation
Sun, Jianmin LU ; Thingholm, Tine LU ; Højrup, Peter and Rönnstrand, Lars LU
(2018)
In Oncogenesis
7(6).
- Contribution to journal › Article
-
Mark
Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
Li, Tianfeng ; Deng, Yi ; Shi, Yu ; Tian, Ruijun ; Chen, Yonglong ; Zou, Lin ; Kazi, Julhash U. LU
; Rönnstrand, Lars
LU
; Feng, Bo
and Chan, Sun On
, et al.
(2018)
In Oncogene
37(47).
p.6180-6194
- Contribution to journal › Article
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
Hyrenius-Wittsten, Axel LU ; Pilheden, Mattias LU ; Sturesson, Helena LU ; Hansson, Jenny LU
; Walsh, Michael P.
; Song, Guangchun
; Kazi, Julhash U.
LU
; Liu, Jian
; Ramakrishan, Ramprasad
LU
and Garcia-Ruiz, Cristian
LU
, et al.
(2018)
In Nature Communications
9(1).
- Contribution to journal › Article
-
Mark
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
Marhäll, Alissa LU ; Heidel, Florian ; Fischer, Thomas and Rönnstrand, Lars LU
(2018)
In Annals of Hematology
97(5).
p.773-780
- Contribution to journal › Article
- 2017
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
Kazi, Julhash U. LU
; Chougule, Rohit A.
LU
; Li, Tianfeng
; Su, Xianwei
; Moharram, Sausan A.
LU
; Rupar, Kaja
LU
; Marhäll, Alissa
LU
; Mohiuddin, Gazi
LU
; Sun, Jianmin
LU
and Zhao, Hui
, et al.
(2017)
In Cellular and Molecular Life Sciences
74(14).
p.2679-2688
- Contribution to journal › Article